Could TDOC stage a quick bounce after this drop, and how should leveraged traders approach it?

Historically, TDOC has produced 39–44% three-month rallies even within a long-term downtrend per Barchart data. Any leveraged long on a mean-reversion thesis should wait for volume confirmation at a clear support level and use tight stops, given the structurally bearish trend.

Which other stocks are most exposed to TDOC's earnings miss as a sympathy trade?

Hims & Hers Health (HIMS) is the most directly comparable digital-health peer and may see negative sentiment spillover. Other app-based or virtual-care platforms with negative EPS profiles are also at risk of de-rating.

Does TDOC's crash affect the S&P 500 or NASDAQ 100 index CFDs?

No material impact — TDOC's sub-$1.2B market cap gives it negligible weighting in major indices. The event is sector-specific with no macro read-through to broad index CFD positions.

How does soft forward guidance affect TDOC's valuation going forward?

Below-consensus revenue guidance triggers downward revisions to DCF models and analyst price targets, compressing the growth multiple further. For a stock already down ~95% from its peak, each guidance cut reduces the base case for any re-rating catalyst.

Snabblänkar

Teladoc Health (TDOC) Crashes ~21% on Earnings Miss: Leverage Scenarios & Sector Contagion

Publicerad: 2026-07-30 10:39:08 UTC

Datasnapshot

TDOC Beta

~2.14

TDOC Session Move

~-21%

TDOC All-Time High

$294.54 (Feb 8, 2021)

TDOC 5-Year Drawdown

~95-96% from ATH

Viktiga punkter

•TDOC fell ~21% post-earnings on a wider-than-expected loss and below-consensus revenue guidance, extending a ~95% decline from its 2021 all-time high.
•Leverage risk is extreme: a 20x long CFD position on TDOC would have been fully liquidated by the earnings gap — position sizing must account for gap-through risk in high-beta names (beta ~2.14).
•Digital health peers like Hims & Hers (HIMS) face sympathy pressure as TDOC's miss reinforces skepticism around virtual-care monetization timelines.
•Broad index impact (S&P 500, NASDAQ 100) is negligible given TDOC's sub-$1.2B market cap, making this a sector-specific rather than macro event.
•Post-gap mean reversions are historically common for TDOC — watch for volume confirmation before taking directional exposure on either side.

The chart illustrates the performance of the NASDAQ 100 Index (US100) over the last 24 hours, opening at 27,869.4 and closing at 27,485.2, reflecting a decline of 1.38%. The index reached a high of 27,949.95 and a low of 27,030.5 during this period. In relation to this, the S&P 500 Index (US500) also experienced a drop of 1.27%. Notably, HIMS saw a significant decline of 14.38%, indicating a pronounced laggard in the market. This downturn in the indices may be attributed to broader market reactions following Teladoc Health's (TDOC) earnings miss, which resulted in a crash of approximately 21%. Traders should be aware of potential leverage scenarios, particularly in light of the contagion effect observed in related stocks and indices. — NASDAQ 100 Index (US100) fell 1.38% amid broader market declines.

Teladoc Health, Inc. (NYSE: TDOC) suffered a sharp single-session decline of approximately 21% following a mixed quarterly earnings report. According to Google Finance, the selloff was triggered by a

Event Summary

Teladoc Health, Inc. (NYSE: TDOC) suffered a sharp single-session decline of approximately 21% following a mixed quarterly earnings report. According to Google Finance, the selloff was triggered by a wider-than-expected net loss and disappointing revenue guidance that fell below Wall Street consensus. The reaction continues a long-running derating: TDOC has shed roughly 95–96% from its all-time high close of $294.54 (February 8, 2021), per Macrotrends data, as repeated earnings shortfalls have systematically reset the stock's growth premium.

This latest miss reinforces that Teladoc's path to profitability remains elusive, undermining the post-COVID telehealth monetization narrative that once justified its peak valuation. With a beta of approximately 2.14 (per Simply Wall St), the stock's outsized reaction is structurally consistent with prior earnings events.

Leverage Impact Analysis

For traders using stock CFDs with high leverage, a ~21% single-session gap is a high-impact event. Consider these scenarios on CoinUnited's up-to-2000x CFD platform:

-Long position wiped: A trader holding a 20x long TDOC CFD faces a notional move of ~420% of margin — well beyond any reasonable stop buffer. At 20x, a 5% adverse move liquidates the position; a 21% gap would have liquidated 4x longs with no possibility of manual exit.
-Short position rewarded — but volatile: A 10x short TDOC CFD would have returned approximately 210% of initial margin on the gap down. However, post-earnings mean-reversion rallies are common in high-beta names (TDOC has previously staged 39–44% three-month rallies per Barchart data), creating asymmetric risk for short-holders who don't reduce size after the event.
-Key lesson: Earnings gaps on high-beta names (beta 2.14) like TDOC can exceed 5–10x the implied move from options pricing. For those trading earnings miss setups, position sizing must account for gap-through risk that bypasses stop-loss orders entirely.

Monitor whether elevated implied volatility collapses post-earnings (IV crush), which could affect any options-adjacent positioning.

Cross-Market Impact

This is primarily a micro/sector event with limited macro spillover. Key cross-market read-throughs:

-Digital health peers: Hims & Hers Health, Inc. (HIMS) and similar app-based health services may trade in sympathy, particularly those still carrying negative EPS profiles. TDOC's miss signals that virtual-care monetization remains structurally challenged.
-Broad indices: TDOC's sub-$1.2B market cap makes its impact on the S&P 500 Index and NASDAQ 100 Index negligible at index level. However, healthtech-focused ETFs with TDOC as a constituent will register a small but notable NAV drag.
-Speculative growth factor: The event adds one more data point to the post-COVID unprofitable-tech deflation theme. Quant factor funds screening for profitability will likely trim high-beta, loss-making healthcare names. This could create mild near-term headwinds for the broader digital health cohort.
-No commodity, FX, or rates impact: Teladoc is a services/software business with no material exposure to commodities, trade flows, or monetary policy channels.

Trading Considerations

Given TDOC's history of sharp post-gap mean reversions (39–44% three-month bounces per Barchart), traders should watch for stabilization volume before positioning directionally. The stock has a structurally weak multi-year trend, but gap-fills and short-squeeze dynamics in low-float, high-beta names are common within days of an earnings shock. Key levels to monitor are the pre-earnings session close and the intraday low from the gap session — a failure to hold the gap low on retests typically signals continuation lower. For those exploring earnings miss recovery setups, wait for price confirmation rather than anticipating a bounce.

Start Trading on CoinUnited.io

Create Your Free Account → — Trade crypto, stocks, forex, indices, and commodities with up to 2000x leverage and zero fees.

Vanliga Frågor

At beta 2.14 and with demonstrated single-session moves of 20%+, leverage above 5x on TDOC carries meaningful liquidation risk from earnings gaps alone — gaps bypass stop-loss orders entirely. Most disciplined traders cap leverage at 3–5x on high-beta, earnings-sensitive names.